PJSC “Pivnichny Mining and Processing Plant” (Pivnichny Mining and Processing Plant, Kryvyi Rih, Dnipropetrovsk Oblast), a member of the Metinvest Group, reported a 94.6% decline in net profit for January–March of this year—to UAH 39.456 million from UAH 731.254 million in the same period last year.
According to the company’s interim report, which is available to the Interfax-Ukraine agency, revenue from ordinary activities for this period increased by 13.2%—to UAH 10,113.454 million.
Retained earnings as of the end of March amounted to UAH 14,828.095 million.
According to the annual report, PivdenGZK reduced its net profit by 2.2 times in 2025, to UAH 595.725 million from UAH 1.338185 billion in 2024. At the same time, revenue from ordinary activities for the past year increased by 13.7%—to 32.917622 billion UAH.
As reported, in 2024, PivdenGZK increased its net profit to 1.338185 billion UAH from 866.090 million UAH in 2023. The company ended 2022 with a net loss of UAH 2.972 billion, while in 2021 it reported a net profit of UAH 25.293 billion.
The plant specializes in the extraction, processing, and production of iron ore.
Metinvest B.V. owns 100% of the shares in Northern GOK.
Northern GOK is part of the Metinvest Group, whose main shareholders are PJSC System Capital Management (SCM, Donetsk) (71.24%) and the Smart Holding group of companies (23.76%). The management company of the Metinvest Group is Metinvest Holding LLC.
PivdenGZK’s authorized capital is UAH 579.707 million.
One of Ukraine’s largest pharmaceutical distributors, Optima-Pharm, Ltd. (Kyiv), saw its net profit drop by 53% in 2025—to nearly 1.67 billion UAH.
As the company reported in its 2025 annual report, sales of goods and services during this period increased by 2.9% to nearly UAH 76.251 billion, while revenue from goods sales rose by 2% to nearly UAH 70.944 billion.
Revenue from the sale of pharmaceuticals amounted to approximately UAH 59.821 billion, which is nearly equal to the 2024 figures; revenue from the sale of dietary supplements increased by 5% to UAH 6.506 billion; revenue from the sale of medical devices increased by 15% to more than UAH 2.643 billion; revenue from cosmetics sales decreased by 11% to 785.957 million UAH.
The company noted that several of Optima-Pharm’s owned and leased warehouses were destroyed as a result of rocket attacks; management assessed and recognized losses in the amount of 2.3 billion UAH.
“Some suppliers have agreed to replenish inventory levels at the company’s warehouses or compensate for the losses in other ways; management continues negotiations with others,” Optima-Pharm notes in the report.
As reported, in May, the Antimonopoly Committee of Ukraine (AMCU) fined “Optima-Pharm, LTD” 7.094 million UAH. The fine was imposed for providing the committee with incomplete information at the request of the AMCU’s deputy chairman.
Earlier, in July 2025, the AMCU fined “BaDM” and “Optima-Pharm, LTD” for violating competition law for a total amount of over 4.8 billion UAH (2.374 billion UAH for ‘BaDM’ and 2.432 billion UAH for “Optima-Pharm, LTD”).
Later, in October, the AMCU decided not to suspend its decision regarding “BaDM” and “Optima-Pharm, LTD,” which had challenged the committee’s decision in court.
In December 2025, the enforcement service, acting on a claim by the AMCU, initiated enforcement proceedings to collect the debt from the pharmaceutical distributor BaDM LLC; in April of this year, similar proceedings were initiated against the joint venture Optima-Pharm, LTD (Kyiv), which are the largest pharmaceutical distributors in Ukraine.
As reported, on November 18, Russian troops once again shelled Optima-Pharm’s warehouses; the company’s warehouse building in Dnipro was completely destroyed. Earlier, on October 25, Optima-Pharm’s warehouse complex and office in Kyiv were damaged by shelling, with losses estimated at $100 million; on August 28 of last year, another Kyiv warehouse belonging to the distributor was destroyed.
As reported to the agency “Interfax-Ukraine” by the AMCU, the committee currently has no information that the fines totaling nearly 4.807 billion UAH imposed on the two largest pharmaceutical distributors, BaDM LLC and Optima-Farm, Ltd. Joint Venture, following the committee’s lawsuit, have been collected.
Cherkasy Bus JSC ended the first quarter of this year with a net profit of UAH 1.33 million, whereas for the same period in 2025, the company reported a loss of nearly UAH 3 million.
According to the interim report published in the NSSMC’s disclosure system, net sales revenue increased by 3% compared to January–March 2025, reaching UAH 240 million.
The plant increased its gross profit by 34% to UAH 39 million, with operating profit growing 2.6-fold to UAH 5 million.
According to the report, in the first quarter, “Cherkasy Bus” manufactured 102 buses worth UAH 295.2 million and 59 trucks worth UAH 98.2 million, while selling 69 buses worth UAH 205.1 million and 17 trucks worth UAH 34.3 million.
The company’s plans, as outlined in its annual report, call for the production of 385 Ataman buses, the assembly of 300 Isuzu trucks, and 302 Isuzu pickups this year (in line with plans for 2025).
At the same time, last year the plant actually reduced bus production by 8% compared to the previous year—to 391 units—and truck production by 1.9% (by 6 units), to 315 units. A total of 393 buses (7.5% fewer) and 240 trucks (24.8% fewer) were sold.
Annual production volume increased by 12.7% overall—to 1.763 billion UAH.
This year, the plant plans to invest 35.8 million UAH in development, specifically in the purchase of technological, transport, and power equipment, the modernization and repair of equipment, production and office facilities, and the improvement of the plant’s grounds.
In 2026, the plan is to begin production of 2- and 3-axle FTS 34 trucks, special-purpose and specialized vehicles on NPR, NQR, FSR, and D-MAX chassis, as well as A092 and A093 buses using Euro 6-compliant chassis.
“Currently, two-thirds of the company’s production consists of orders from the public sector,” the report states.
Founded in 1994, the “Cherkasy Bus” plant manufactures Ataman small-class buses (including city, suburban, school, and specialized models), as well as other wheeled vehicles based on Japanese Isuzu components, specifically, through the large-assembly method for Isuzu trucks with a payload capacity of 3 to 18 tons (dump trucks, fire trucks, emergency repair vehicles, aerial work platforms, and vehicles with superstructures—for Ukrposhta, local communities, and the State Border Guard Service).
It also manufactures Isuzu pickups for the National Police, the State Emergency Service, the State Border Guard Service, forest patrols, and energy and gas companies.
The plant ended 2025 with a net profit of nearly 83 million UAH—32% less than in 2024—amid a slight decline in net revenue to 1.733 billion UAH. It did not plan to pay dividends.
As of the beginning of this year, the company employed 374 people—33 fewer than at the start of 2025—and the average monthly salary for the year increased by 25.5% to 35,750 UAH.
The state-owned company Ukrposhta reported a total profit of UAH 106.3 million for January–April, with EBITDA of UAH 122.9 million, the company’s CEO Ihor Smiliansky announced on Facebook on Monday.
“EBITDA (operating profit)—a measure of the core business’s performance—improved from a negative 13.6 million UAH to a positive 122.9 million UAH. And this is without taking into account the sale of assets. It consists solely of operating income,” he noted.
According to the CEO, the company’s equity reached UAH 2.3 billion without additional budget funding.
“So, who doesn’t have the cards, and who holds the trump cards right now?” Smiliansky concluded in a remote discussion with Andriy Pyshnyy, Governor of the National Bank of Ukraine, regarding Ukrposhta’s financial capacity to “restore and accumulate capital through operating activities” and obtain a banking license.
As reported, Ukrposhta posted a net loss of 204.8 million UAH for January–March 2026, which is 1.1 million UAH, or 0.5%, higher than in the same period of 2025, while its revenue grew by 1.1% to 13.11842 billion UAH.
The company’s equity in the first quarter of this year decreased from UAH 2.208 billion to UAH 2.003 billion.
In April of this year, Ukrposhta received UAH 461.5 million for its building, the former sorting center near the railway station in Lviv, which was purchased by the Eurotek Invest fund owned by Mykhailo Veselskyi, the owner of the Arsen supermarket chain.
PJSC “Scientific and Production Center ”Borshchahivsky Chemical and Pharmaceutical Plant” (BCPP) increased its net profit by 2.96% to UAH 281.788 million in 2025.
According to the company’s website, BCHP increased its production of pharmaceutical products by 16% in 2025, reaching 37.4 million packages worth UAH 2.481 billion.
According to the company, total sales of finished products and goods in 2025 amounted to 43.8 million packages, which is 6.9% more than in 2024.
In addition, the company reported that in 2025, BHFZ exported products worth UAH 307 million, accounting for 13.7% of total sales.
BHFZ exported its products to countries in Eastern and Western Europe, the Baltic states, the Caucasus, Central Asia, and other distant foreign markets, as well as to countries within the CIS.
Net sales revenue for 2025 amounted to UAH 2.259 billion, which is 7.9% more than the previous year.
BHFZ forecasts an 18% increase in net sales revenue for 2026 compared to 2025. Annual growth during 2027–2028 is expected to be 13%
The company also reported that in 2025, BHFZ was developing 12 drugs in four dosage forms; one clinical trial was completed, and preparations are underway for two more clinical trials.
Additionally, BHFZ completed the registration process for one drug in Ukraine and seven abroad.
In total, in 2025, BHFZ registered four finished pharmaceutical products and five APIs. One drug was submitted for registration in CIS countries, and four drugs were registered in countries outside the CIS.
The company noted that BHFZ is striving to maintain retail prices at pre-war levels and has adjusted its product portfolio to account for wartime conditions; it has also managed to maintain the continuity of supply chains.
In addition, the BHFZ Group has created the necessary reserve of production stocks and raw materials, which is constantly updated, to ensure uninterrupted production throughout 2026.
As reported, BHFZ is seeking to recover UAH 50.7 million in damages from the Russian Federation for the destruction and damage of property resulting from armed aggression, specifically the destruction and damage of property caused by a rocket attack on July 31, 2025.
The court accepted the statement of claim for consideration and opened proceedings in the case. As part of the investigation, an expert assessment was conducted, according to which the amount of direct (actual) damages caused to BHFZ as a result of the loss, destruction, or damage to property (fixed assets and inventory according to the lists) in connection with the armed aggression of the Russian Federation (as a result of the explosion and fire on July 31, 2025) amounts to UAH 50,760,894, which, at the NBU exchange rate as of the date of the assessment (July 31, 2025), is equivalent to $1,215,358.
Currently, the shareholders of BHFZ are the pharmaceutical company PJSC “Pharmaceutical Firm ‘Darnitsa’ (Kyiv), which owns 31.8% of BHFZ’s shares; other shareholders include ”Beldor Group“ (21.26%) and ”Lenik Group” (20.32%) .
The ultimate beneficiaries of BHFZ are the beneficiaries of the pharmaceutical company “Darnitsa”: Gleb Zagoriy, Yevgen Sova, Tetiana Artemenko, Mykola Bezpalko, and Oleg Goloborodko.
Shuvar LLC (Lviv), which operates the Lviv agricultural market of the same name, reported a net profit of 136.4 million UAH for 2025, a 49% increase over the previous year.
According to the company’s annual report, published in the disclosure system of the National Securities and Stock Market Commission (NSSMC), pre-tax profit amounted to UAH 168.3 million.
As noted in the financial report, the company’s gross profit increased by 21.5% compared to the previous year, reaching UAH 158.8 million. Net revenue rose by 10.1% to UAH 305.4 million.
Shuvar LLC’s retained earnings in 2025 grew by 10.7% to UAH 566.8 million. The company’s current liabilities as of the end of 2025 decreased by 38.3% to UAH 88.6 million, while long-term liabilities decreased by 3.3% to UAH 120.4 million. The company’s assets in 2025 grew by 1.4% to UAH 796.8 million.
According to data from the YouControl analytical system, the owners of Shuvar LLC are Regional Agricultural and Marketing Center “Shuvar” LLC (85%), Agricultural Products Market “Shuvar” LLC (10%), and Tetiana Ambroskina (5%). The ultimate beneficiaries are listed as Andriy Chipchar and Roman Fedyshyn.
“Shuvar” is the largest wholesale agricultural market in Lviv, in western Ukraine. The market covers a total area of over 20 hectares and has 480 permanent tenants. It is a member of the World Organization of Wholesale Markets. On average, 1.4 million vehicles enter the market grounds each year. The market is part of the “Shuvar” group of companies, managed by Shuvar LLC.
